Enhancer ID: | E_02_0087 |
Species: | human |
Position : | chr8:144311848-144313848 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 29556394 |
Enhancer experiment: | Proliferation study,Differentiation study,Differentiation study,Cytochemical staining |
Enhancer experiment description: | Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study. |
Target gene : | DGAT1,FAS,CPT2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study. |
TF name : | -- |
TF experiment: | Proliferation study,Differentiation study,Differentiation study,Cytochemical staining |
TF experiment description: | Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study. |
Enhancer function : | Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|